Cortical thinning in obsessive compulsive disorder
✍ Scribed by Yong-Wook Shin; So Young Yoo; Jun Ki Lee; Tae Hyon Ha; Kyung Jin Lee; Jong Min Lee; In Young Kim; Sun I. Kim; Jun Soo Kwon
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 283 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1065-9471
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Although studies of obsessive–compulsive disorder (OCD) over the last 20 years have suggested abnormalities in frontal‐subcortical circuitry, evidences of structural abnormalities in those areas are still imperfect and contradictory. With recent advances in neuroimaging technology, it is now possible to study cortical thickness based on cortical surfaces, which offers a direct quantitative index of cortical mass. Using the constrained Laplacian‐based automated segmentation with proximities (CLASP) algorithm, we measured cortical thickness of 55 patients with OCD (33 men and 22 women) and 52 age‐ and sex‐matched healthy volunteers (32 men and 20 women). We found multiple regions of cortical thinning in OCD patients compared to the normal control group. Patients with OCD had thinner left inferior frontal, left middle frontal, left precentral, left superior temporal, left parahippocampal, left orbitofrontal, and left lingual cortices. Most thinned regions were located in the left ventral cortex system, providing a new perspective that this ventral cortical system may be involved in the pathophysiology of OCD. Hum Brain Mapp, 2007. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
We examined the presence of disordered thinking/perception in patients with obsessive-compulsive disorder (OCD). Recently, an obsession model has been proposed, which classifies obsessions into two different subtypes: autogenous obsessions and reactive obsessions . Based on this model, we hypothesiz
## Abstract Pharmacotherapeutic options for obsessive‐compulsive disorder (OCD) have expanded over the past half‐century since medications were first found to be effective for the treatment of OCD. Currently, the serotonin reuptake inhibitors (SRIs) represent the first‐line pharmacotherapy for OCD.
The distribution of obsessive compulsive symptoms was compared in 16 individuals with primary obsessive compulsive disorder (OCD) and 16 individuals with Gilles de la Tourette syndrome (GTS) and associated obsessive compulsive behaviors (OCB). The two groups showed significant differences in the dis